Fig 1: Sigma-1 receptor activation regulated Myrf expression in stroke in diabetic mice. (A,C) Myrf immunohistochemistry was performed to detect oligodendrogenesis in the CA1 and the SL–SE hippocampal layers at 1, 7, and 21 d after ET-1 injection. (B,D) Quantification of the area of the Myrf-immunostained cells in the CA1 and SL–SE of the hippocampus. n = 4–5/group. Scale bars = 50 μm. * p < 0.05, ** p < 0.01, *** p < 0.001.
Fig 2: ANGPTL2-MAG induces Fyn-mediated signaling to enhance the differentiation of oligodendrocytes. A Gene Ontology (GO) analysis of the downregulated differentially expressed genes (DEGs) in the brains of Angptl2+/+ and Angptl2−/− mice at day 15 as determined by RNA sequencing (n = 3). B Enrichment score plots from GSEA related to the GO signature for myelin sheath and ensheathment of neurons (n = 3). FDR, false discovery rate; NES, normalized enrichment score. C Relative mRNA levels of potential candidates related to myelination markers, transcription factors, metabolic regulators and other genes in the brain tissues of Angptl2+/+ and Angptl2−/− mice at day 15 as measured by quantitative RT-PCR (n = 3). D Immunoblot analysis of MYRF and ANGPTL2 protein levels in the brain tissues of Angptl2+/+ and Angptl2−/− mice at day 5, day 15 and day 35. Ratio of MYRF/β-actin was quantified and normalized against Angptl2+/+, respectively. One representative experiment is shown. E–F Immunoblot analysis of MYRF protein levels in the brain tissues of Mag+/+ and Mag−/− mice (E) or Mag−/−Angptl2+/+ and Mag−/−Angptl2−/− mice (F) at day 5, day 15 and day 35. Ratio of MYRF/β-actin was quantified and normalized against Angptl2+/+, respectively. One representative experiment is shown. G–H MAG directly interacted with FYN, as detected by forward (G) or reverse (H) co-immunoprecipitation assays. CMV-MAG (full-length)-FC and pLVX-FYN-strepII plasmids were used in this experiment. One representative experiment is shown. I RSC96 cells with ectopic expression of MAG (full-length)-FLAG and FYN-StrepII were treated with ANGPTL2 proteins, followed by co-immunoprecipitation analysis to evaluate the changes in tyrosine phosphorylation levels of MAG and FYN using 4G10 and p-SRC (Tyr416) antibodies, respectively. The levels of immunoprecipitated protein were quantified and normalized against the control group, respectively. One representative experiment is shown. J RSC96 cells overexpressing FYN-StrepII or MAG (full-length)-FC were subjected to immunoblot analysis to determine MYRF protein levels. Ratio of MYRF/β-actin was quantified and normalized against negative control (empty vector), respectively. One representative experiment is shown. K Western blot analysis of the protein levels of P-SRC (Tyr416), Fyn and MBP in HCN cells 72 h after induction with IGF1 (100 ng/ml), with/without ANGPTL2-Flag (2 μg/ml) and AZD0530 (2 μM) as indicated. Ratios of P-SRC (Tyr416)/β-actin, Fyn/β-actin, MYRF/β-actin and MBP/β-actin were quantified and normalized against the control treated with IGF1 alone, respectively. One representative experiment is shown. L Schematic diagram of the working model for the role of ANGPTL2-MAG in oligodendrocytes differentiation, myelination and differentiation. (***p < 0. 001)
Supplier Page from ABclonal Technology for MYRF Rabbit pAb